In October 2024, the Wincent Lab at Karolinska Institutet started testing the effects of NEMESIS focus-compounds on adverse outcomes using zebrafish, a non-mammalian model, as part of the in vivo work done in the NEMESIS project. Malin Lundvall, a Master’s student, and Oscar Diaz, Postdoc, performed the initial testing and evaluated the effects of 8 […]

NEMESIS has run for just over one year and it was time to see where the project is at. The consortium members met at a General Assembly meeting in Barcelona on 29-30 January 2025 to discuss the progress of the project and the next steps. The meeting was arranged at CSIC Spanish National Research Council […]

Subscribe now to receive in your inbox the ENKORE Cluster newsletter on the latest news and advances on the health impacts of endocrine-disrupting chemicals from European research institutions and five Horizon Europe funded projects: NEMESIS as well as EDC-MASLD, ENDOMIX, HYPIEND and MERLON. During the ENKORE cluster lifespan, just a total of three newsletters will be sent with cluster […]